12-Month Analysis of ILLUMINATE-A, a Phase 3 Study of Lumasiran: Sustained Oxalate Lowering and Kidney Stone Event Rates in Primary Hyperoxaluria Type 1Jeffrey M. Saland, John C. Lieske, Michael J. Koren et al.|Journal of the American Society of Nephrology|2020Cited by 4
Natural History of Advanced Primary Hyperoxaluria Type 1: A Retrospective StudyJohn C. Lieske, John M. Gansner, Jaap W. Groothoff et al.|Journal of the American Society of Nephrology|2023Cited by 0